ImmunoPrecise Antibodies IPA Balance Sheet

Income Statement

Quarter End	Jan 2022	Apr 2022	Jul 2022	Oct 2022	Jan 2023	Apr 2023	Jul 2023	Oct 2023
	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)
Total Assets	56.45M	93.49M	79.94M	82.75M	82.44M	77.81M	76.58M	75.61M
Total Current Assets	40.56M	37.47M	27.09M	22.68M	18.87M	16.79M	15.72M	15.41M
Cash and Equivalents	32.99M	29.97M	19.24M	15.06M	11.32M	8.28M	6.73M	6.02M
Total Non-Current Assets	19.46M	59.36M	55.97M	69.68M	74.03M	71.41M	73.19M	72.07M
Total Liabilities	8.76M	18.21M	13.7M	21.01M	21.36M	20.01M	22.74M	23.58M
Total Current Liabilities	7.14M	9.26M	5.36M	7.31M	6.65M	5.92M	6.42M	7.53M
Total Non-Current Liabilities	1.62M	8.95M	8.35M	13.71M	14.71M	14.09M	16.32M	16.04M
Common Equity	81.79M	114.56M	116.18M	117.05M	117.22M	117.47M	117.47M	117.47M
Retained Earnings	-41.88M	-46.53M	-55.91M	-63.26M	-67.96M	-73.09M	-76.65M	-79.28M

Year End April 29 2023	2016	2017	2018	2019	2020	2021	2022	2023
	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)	CAD ($)
Total Assets	1.38M	3.93M	24.58M	28.35M	27.26M	66.96M	93.49M	77.81M
Total Current Assets	1.22M	3.28M	4.78M	9.88M	7.7M	48.86M	37.47M	16.79M
Cash and Equivalents	340k	2.58M	1.81M	5.47M	2.61M	41.76M	29.97M	8.28M
Total Non-Current Assets	908k	3.09M	12.7M	18.07M	15.09M	56.92M	75.29M	57.8M
Total Liabilities	472k	836k	11.87M	10.28M	12.18M	10.04M	18.21M	20.01M
Total Current Liabilities	385k	836k	4.28M	7.2M	7.93M	6.07M	9.26M	5.92M
Total Non-Current Liabilities	87k	0	11.22M	3.17M	4.44M	5.49M	8.95M	14.09M
Total Equity	908k	3.09M	12.7M	18.07M	15.09M	56.92M	75.29M	57.8M
Common Equity	0	7.46M	20.46M	32.7M	34.09M	80.1M	114.56M	117.47M
Retained Earnings	908k	-4.57M	-9.46M	-17.7M	-22.48M	-29.82M	-46.53M	-73.09M